Jean-Michel Boers serves as the President and Chief Executive Officer of Boehringer Ingelheim USA Corporation. In this executive capacity, he oversees the corporation's extensive human pharmaceutical, animal health, and clinical research operations across the United States, driving the successful commercialization and development of specialty care therapies addressing complex medical conditions.